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Objective: Extracranial carotid stenosis is a complication of external head and neck irradiation. The safety and durability
of carotid artery revascularization through a radiated field has been debated. We describe the immediate and long-term
results in a series of 27 consecutive patients who received treatment over 12 years.
Methods: From May 1990 to May 2002, 27 consecutive patients underwent 30 primary carotid artery revascularization
procedures. All patients had received previous radiation therapy within a mean interval of 10 years (range, 1-26 years),
with average radiation dose of 62 Gy (range, 50-70 Gy). Moderate to severe scarring of the skin or radiation fibrosis was
present in three fourths of patients. Thirteen patients (48%) had undergone radical neck dissection, and 2 patients had a
permanent tracheotomy. The indications for carotid surgery included high-grade (>70%) symptomatic stenosis in 18
patients (60%) and high-grade asymptomatic stenosis in 12 patients (40%). General anesthesia with systematic shunting
was used in 18 patients (60%), and regional anesthesia with selective shunting was used in 12 patients (40%). Operations
included standard carotid endarterectomy (n  20), with patch angioplasty (n  12) or direct closure (n  8); carotid
interposition bypass grafting (n  7); and subclavian to carotid bypass grafting (n  3). Primary closure of the surgical
wound was performed in all procedures without any special muscular or skin flaps. All patients were followed up for a
mean of 40 months (range, 3-99 months).
Results: There was one (3.3%) perioperative death, from massive intracerebral hemorrhage; and 1 patient had a transient
ischemic attack. In-hospital complications included neck hematoma in 2 patients, which required surgical drainage in 1
patient. There was neither delayed wound healing nor infection. Twelve patients died during follow-up, of causes not
related to treatment. None of the surviving patients had further stroke, and all remained asymptomatic. Follow-up duplex
scans showed asymptomatic recurrent stenosis greater than 60% in 3 patients, 2 of whom with stenosis greater than 80%
underwent repeat operation. Risk for recurrent stenosis greater than 60% at 18 months was 16.6%. Recurrent stenosis
occurred in 2 of these patients after saphenous vein bypass, and in 1 patient after endarterectomy with vein patch
angioplasty.
Conclusion: The clinical results and sustained freedom from symptoms and stroke over 40-month follow-up suggests that
carotid revascularization through a radiated field is a safe and durable procedure in patients at high surgical risk, despite
a marked incidence of recurrent stenosis. (J Vasc Surg 2003;38:244-50.)
Radiation-induced accelerated atherosclerosis has been
recognized for some time.1-4 Because of the prolonged
survival of patients treated with radiation,5 the frequency of
this long-term side effect is expected to increase. In a
prospective study, late (70%) carotid artery stenosis was
found in 11.7% of 240 patients who had undergone cervical
irradiation.6 The chronic effects of radiation therapy lead to
decreased vascularity and increased fibrosis, which in turn
lead to risk for tissue necrosis, infection, and ulceration. In
addition, many stenoses involve extensive segments of the
carotid artery and other supra-aortic vessels, which renders
surgical management more demanding.7,8 No prospective
randomized study exists to guide optimal therapy in pa-
tients with radiation-induced accelerated high-grade ca-
rotid stenosis who do not fit eligibility criteria set forth in
the major clinical trials.9,10 Furthermore, the potential
additional morbidity incurred from treatment in patients
who have undergone radiation therapy may invalidate the
documented benefit of surgical carotid revascularization.
Thus, to elucidate factors important in the management of
these cases and to assess safety and durability of the proce-
dure, we reviewed our experience over 12 years.
PATIENTS AND METHODS
From May 1990 to May 2002, data were retrospec-
tively collected for patients who had undergone carotid
revascularization after therapeutic irradiation in our De-
partment of Vascular and Thoracic Surgery (Beaujon Uni-
versity Hospital, Clichy, France). These data included de-
mographics, medical condition and initial symptoms,
surgical risk factors according to the grading system of
Sundt et al,11 preoperative factors associated with radiation
therapy, surgical details, and perioperative morbidity. Pre-
operative workup included Doppler ultrasound (US) scan-
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ning and contrast material–enhanced arteriography in all
patients and brain computed tomography (CT) in patients
with symptoms. Preoperative ear, nose, and throat evalua-
tion was conducted in all patients, to assess possible imped-
iments to tracheal intubation and vocal cord mobility.
Operative technique. Surgery was performed with
the patient under either general endotracheal anesthesia or
regional anesthesia. Regional anesthesia was induced with
superficial block alone, with additional skin supplementa-
tion. Additional local anesthesia was often necessary in the
carotid sheath when dissecting cephalad. All patients who
received general anesthesia underwent systematic shunting,
if technically possible; in patients who received regional
anesthesia, only patients with neurologic changes during
cross-clamping underwent shunting. All patients received
intraoperative systemic anticoagulation therapy with hepa-
rin (75 IU/kg) before vascular clamping. The carotid
artery was exposed through a longitudinal neck incision
anterior to the sternocleidomastoid muscle. When neces-
sary, the subclavian artery was exposed separately through a
supraclavicular incision. Previous ipsilateral neck incisions
were occasionally used. Care was taken to preserve all
nerves. Surgery included standard carotid endarterectomy
with patch angioplasty or direct closure, carotid interposi-
tion grafting, and subclavian to carotid bypass grafting.
Since 1996, duplex US scanning has been routinely per-
formed at completion of the operation before wound clo-
sure. Intraoperative duplex US scanning was performed in
19 patients.
Postoperative management and follow-up examina-
tion. Patients remained in an intensive care setting for 12
to 24 hours, depending on comorbid conditions. Members
of the anesthesiology department and a neurologist, when
required, performed initial in-patient neurologic examina-
tions and clinical management. Patients in whom carotid
endarterectomy was planned received preoperative (1 week
before the procedure) oral antiplatelet therapy. Patients in
whom bypass grafting was planned received oral antiplate-
let therapy on the day of the procedure. From the day of the
procedure to discharge from the hospital, all patients re-
ceived low molecular weight heparin at a prophylactic dose
(Nadroparin, 3075 anti-factor Xa IU/d). After discharge,
only oral antiplatelet therapy was routinely prescribed. Fol-
low-up neurologic examination and ultrasonography (Ul-
tra Mark 4 Plus, Advanced Technology Laboratories,
Bothel, Wash; and SONOS 5500, Hewlett Packard, An-
dover, Mass) were performed in our department by the
angiology team on the day of discharge and at 1 month and
6 months of follow-up, then yearly. Recurrent stenosis was
defined as reduction in vessel diameter of more than 50%
(peak systolic velocity 140 cm/s). For the purposes of
this report, status of all survivors was updated in September
2002.
Quantitative analysis and statistics. Severity of ste-
nosis was computed with the method of the North Amer-
ican Symptomatic Carotid Endarterectomy Trial
(NASCET).9 Patency and survival rates were determined
with standard life-table analysis with the Kaplan-Meier
method.
RESULTS
Over the past 12 years, 1024 patients underwent ca-
rotid revascularization in our department. Of these, 29
consecutive patients (2.8%) underwent carotid revascular-
ization after therapeutic neck irradiation. Two of these
required surgery because of tumor invasion and were ex-
cluded. Thus the study group included 27 patients who
underwent 30 primary carotid revascularization proce-
dures. The demographic characteristics, comorbid medical
conditions, and initial symptoms in these patients are pre-
sented in Table I. Most patients (67%) had a history of head
and neck squamous cell carcinoma, which led to neck
irradiation (Table II). A mean therapeutic radiation dose of
62 Gy (range, 50-70 Gy) was administered, and a mean
interval of 10 years (range, 1-26 years) elasped between
radiation therapy and carotid revascularization. Twenty
patients (74%) had moderate to severe scarring of the skin
or radiation fibrosis. Thirteen patients (48%) underwent
radical neck dissection, and 2 patients had a permanent
tracheotomy. Fifteen patients (56%) had sustained one or
more previous clinically significant strokes (major, n  3;
minor, n  3) or hemispheric transient ischemic attacks
(TIA) (n 9) in the territory of the treated vessel (Table I).
Table I. Patient demographic characteristics, medical
conditions, risk factors, and symptoms
Variable n %
Age (y)
Mean  SEM 66.7  9,18
Median 66
Range 48-84
Distribution
70 y 16
70-79 y 9
80 y 2
Sex
Male 20 74
Female 7 26
Medical conditions (n  27 patients)
Smoking 17 63
Hypertension 14 52
Previous MI or angina 9 33
Hypercholesterolemia 4 15
Diabetes mellitus 4 15
Severe PVD 4 15
Previous contralateral stroke 2 7
Hemodialysis 2 7
Symptoms (n  30 stenoses)
Asymptomatic high-grade stenoses 12 40
Symptomatic high-grade stenoses 18 60
Previous stroke 6
Hemispheric TIA 9
Retinal TIA 3
MI, Myocardial infarction; PVD, peripheral vascular disease; TIA, transient
ischemic attack.
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Most patients fulfilled the criteria for medical (16 of 27
patients, 59%), angiographic (17 of 27 patients, 63%), and
neurologic (10 of 27 patients, 37%) risk factors defined by
Sundt et al11 and Sieber et al.12
Lesion characteristics and technique. Twenty-four
patients had unilateral stenosis, and 3 patients had bilateral
stenosis. Among these 30 stenoses, 17 (56%) were left-
sided, 15 (50%) were located mainly at the carotid bifurca-
tion (bulb), 5 (17%) were in the common carotid artery,
and 10 (33%) were in the distal (post-bulb) internal carotid
artery. Mean grade of stenosis was 84.6% 8.3%. Morpho-
logic characteristics of stenosis included presence of an
ulcerated or irregular plaque in 21 patients (70%). Sixteen
patients (59%) had 50% or greater stenosis in the contralat-
eral internal carotid artery, and in 6 of these patients (22%)
the artery was completely occluded. Fourteen patients
(52%) had 50% or greater extracranial posterior circulation
disease, and 9 of these patients (33%) had complete occlu-
sion of one (n  8) or two (n  1) vertebral arteries.
Intracranial atherosclerotic disease was not analyzed in this
study.
General anesthesia was administered in 18 of 30 oper-
ations (60%), with systematic shunting when technically
possible (14 of 18 patients, 78%). In four patients shunting
was not performed because of high-lying lesions. Regional
anesthesia was used in the remaining 12 operations (40%),
with selective shunting in 1 patient. Conventional carotid
endarterectomy was performed in 20 patients (67%), with
patch angioplasty in 12 (60%) or direct closure in 8 (40%).
Saphenous vein was used as the patch material in 5 patients,
and polytetrafluoroethylene (PTFE) was used in 7 patients.
Carotid interposition venous bypass grafting was per-
formed in 7 patients. Ipsilateral (n  1) or cross (n  2)
subclavian to carotid PTFE bypass grafts were used in 3
patients, because of extensive involvement or occlusion of
the ipsilateral common carotid artery in 1 patient and
complete occlusion of the ipsilateral subclavian artery in 2
patients. One patient with complete occlusion of the con-
tralateral carotid artery and bilateral complete occlusion of
proximal vertebral arteries underwent combined simulta-
neous standard carotid endarterectomy with vein patch
angioplasty and ipsilateral subclavian to vertebral venous
bypass grafting. Direct closure of the surgical wound was
always possible without plasty or flap placement. Mean oper-
ative time was 147 minutes (range, 93 to 201 minutes).
Early outcome. There was one perioperative death in
this series (1 of 27 patients, 3.7%; 1 of 30 operations, 3.3%),
due to massive intracerebral hemorrhage. This patient un-
derwent right carotid interposition venous bypass grafting
6 weeks after a right hemispheric minor stroke, with un-
eventful recovery. Four months later the patient returned
to our department, 10 days after having a left hemispheric
major stroke. Left carotid interposition venous bypass
grafting was performed, with general anesthesia and shunt-
ing, but the patient died on the seventh postoperative day
of massive intracerebral hemorrhage. There were no other
major or minor strokes. One hemispheric TIA occurred
during dissection of the carotid bifurcation, before cross-
clamping, in an 84-year-old woman (Sundt grade 3) during
carotid interposition venous bypass grafting with regional
anesthesia to treat symptomatic ulcerated stenosis. The
immediate postoperative hospital course was complicated
by two cervical hematomas (2 of 27 patients, 7.4%; 2 of 30
operations, 6.6%), one of which required surgical evacua-
tion. These patients had not received preoperative anti-
platelet therapy. No perioperative cranial nerve injury, de-
layed wound healing, or infection was documented. Mean
length of hospital stay was 4.9  2.9 days. Duplex US
scanning on the day of discharge demonstrated widely
patent revascularization in all surviving patients.
Late outcome. Clinical follow-up was performed in all
27 patients, for amean of 40months (range, 3-99months).
During follow-up 12 patients died of causes unrelated to
treatment. During follow-up all patients remained free of
new symptoms or new stroke. Duplex US follow-up scans
were available at 6 months for 24 patients (89%), at 12
months for 20 patients (74%), and at 24 months for 15
patients (55.5%).
There was no late carotid artery thrombosis. In 3
patients without symptoms, recurrent stenosis of 60% or
greater developed. In 2 patients who underwent carotid
interposition venous bypass grafting recurrent stenosis was
greater than 80%. In one of these patients, recurrent steno-
sis developed proximal to the cephalad anastomotic suture
line 12 months after surgery. This patient underwent an-
gioplasty without stenting; however, greater than 80% ste-
nosis recurred 6 months after angioplasty, and the patient
has chosen to not undergo repeat operation. In the second
patient, recurrent stenosis developed proximal to the cau-
dal anastomotic suture line 18 months after surgery. In
addition, contrast-enhanced arteriographs showed severe
progressive stenosis of the proximal ipsilateral common
carotid artery. In this patient an ipsilateral subclavian to
carotid PTFE bypass graft was placed successfully and re-
mains patent after 79 months. The third patient underwent
carotid endarterectomy with venous patch angioplasty;
however, 65% restenosis developed proximal to the distal
edge of the venous patch 7 months after surgery. This
patient is currently under close surveillance. The remainder
of the patients had widely patent vessels at follow-up duplex
US scanning. Life-table analysis at 36 months revealed a
Table II. Preoperative factors associated with radiation
therapy
Preoperative factor n %
Cancer history (n  27)
Squamous cell 18 67
Breast 4 15
Lymphoma 3 11
Parotid 2 7
Previous ipsilateral scars
Neck dissection 13 48
Permanent
Tracheostomy
2 7
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cumulative survival rate of 65% (Fig 1), a cumulative pri-
mary patency rate of 90%, and a cumulative patency rate
without recurrent stenosis of 86% (Fig 2). Median survival
was 63 months for patients with symptomatic disease and
75 months for patients with asymptomatic disease.
DISCUSSION
We reviewed the immediate and long-term outcome in
27 consecutive patients who underwent 30 primary carotid
artery revascularization procedures through a radiated field
Fig 1. Percent survival rate with life-table analysis. Error bars represent SEM.
Fig 2. Primary patency rate and patency rate without recurrent stenosis with life-table analysis. Error bars represent
SEM.
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to determine factors that are important for management
and to assess the safety and durability of this challenging
surgery. This series is representative of the community
rather than of a tertiary referral center, in that most of our
patients underwent radiation therapy in the surrounding
area. Although the number of cases reported is small, this is
the largest surgical series described in the literature. Avail-
able data to guide optimal therapy in patients who have
undergone radiation therapy who fail to meet the criteria
set forth in large carotid endarterectomy trials are scarce. In
the past 5 years there have been an increasing number of
reports of carotid revascularization through a radiated
field7,13-18 (Table III). However, these studies are difficult
to compare because they were performed with heteroge-
neous patient populations, with different lesions and out-
come criteria.
Despite extensive investigation, it is still unclear
whether radiation induces atherosclerosis or accelerates its
formation in susceptible patients. Identification of radia-
tion-induced accelerated atherosclerosis of the carotid sys-
tem is mademainly on the basis of clinical and angiographic
parameters. These parameters were present in the present
cohort, and included (1) appropriate history of neck irradi-
ation; (2) lesser presence of cardiovascular risk factors or
other atherosclerotic locations; in our study, coronary ar-
tery disease, hypertension, smoking history, and diabetes
risk factors were less common than in the North American
Symptomatic Endarterectomy Trial9 or the Asymptomatic
Carotid Artery Stenosis Trial,10 but angiographic risk fac-
tors were noted more frequently; and (3) unusual location
of carotid stenosis; 50% of stenoses were located in the
common carotid artery or in the distal internal carotid
artery.
As in most other published series, general anesthesia
was administered in most patients.15-18 In the earlier years
of this series, general anesthesia was elected for all patients,
because of concern that the dissection would be difficult.
Along with general anesthesia, shunts were placed in all
patients if technically possible. However with increasing
experience, 10 of the last 15 procedures were performed
with the patient under regional anesthesia, and use of
general anesthesia was limited to patients with tracheos-
tomy or severe cutaneous or soft tissue sclerosis with or
without previous radical neck dissection. All patients who
received subclavian to carotid bypass grafts received general
anesthetic. Regional anesthesia, previously reported by
Rockman et al15 and Friedell et al18 in 21% and 29% of their
cohorts, respectively, was possible in more than half of our
patients (3 patients chose general anesthesia), and was used
in 40% of patients. Regional anesthesia was well-tolerated
by all patients, and the surgeons believed the technique was
simple, reliable, and easy to monitor.
In the earlier years of this series, concern for radiation-
induced arteritis and the technical difficulty of surgery led
to a preference for carotid interposition bypass grafting.
However, as we gained experience with the “hostile neck,”
endarterectomy was increasingly used, and was successfully
performed in 67% of all cases. At present, carotid endarter-
ectomy with patch angioplasty is our treatment of choice,
and carotid interposition bypass grafting is chosen in cases
of high-lying stenosis distal to the lower edge of the digas-
tric muscle or extensive involvement of the distal common
carotid artery. Moreover, if endarterectomy is impossible
because of severe radiation panarteritis or if the remaining
vessel wall after endarterectomy is too severely attenuated,
bypass grafting of the diseased arterial segment is necessary.
However, we have not encountered these problems. Ini-
tially we, like others,7,8,15 used autologous saphenous vein
for patch angioplasty and bypass grafting, because of po-
tentially better resistance to infection. However, inasmuch
as early recurrent stenosis in 3 patients in this series devel-
oped after saphenous vein bypass grafting in 2 patients and
carotid endarterectomy with vein patch angioplasty in the
third, we converted to use of PTFE grafts, with no wound-
related complications or early recurrent stenosis. Although
no conclusions can be drawn from this limited experience,
Table III. Results of major clinical studies of carotid revascularization in patients with previous neck irradiation
Andros et al7
(1996)
Rockman et al15
(1996)
Kashyap et al16
(1999)
Hassen-Khodja et al17
(2000)
Friedell et al18
(2001)
No. of patients 9 10 24 17 10
No. of revascularizations 9 13 25 18 11
Indications
Symptomatic (%) 67 46 70 67 45
Asymptomatic (%) 33 54 30 33 55
Type of operation
Endarterectomy (n/%) 4 (44) 10 (71) 24 (96) 12 (67) 11 (100)
Carotid bypass (n/%) 5 (56) 4 (29) 1 (4) 6 (33) 0
Overall 30-day neurological
morbidity and mortality
0 1 stroke 0 0 0
Mean follow-up (mo) (range) 25 (NA) NA NA (1–156) 52 (12–108) 37 (12–60)
No. of carotid restenosis or occlusion
during follow-up
1 NA 3 2 1
Stroke or TIA during follow-up 1 stroke 1
TIA
1 stroke 0 1 TIA 0
TIA, Transient ischemic attack; NA, data not available.
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we believe the preferential use of autologous vein should be
further evaluated. Furthermore, a note of caution is to be
made regarding use of autogenous material for bypass
grafting in necks with extensive fibrosis. Synthetic material
appears to withstand external compression better and is less
susceptible to encroachment by scarring.
When proximal lesions of the common carotid artery
were present, particularly on the left side, a subclavian to
carotid PTFE bypass graft was our choice (3 patients).
When the ipsilateral subclavian artery was involved in the
sclerotic process or was occluded, crossover bypass grafting
was necessary (2 patients).
Although the present series included only trial-ineligi-
ble patients with a high proportion of Sundt grade 3 and 4
disease, the 30-day perioperative combined risk for stroke
and death in patients with symptomatic stenosis (5.5%) and
asymptomatic stenosis (0%) is comparable to that reported
in major trials9,10 and in analysis of multiple published
endarterectomy studies by Rothwell et al (5.18% symptom-
atic, 3.35% asymptomatic).19 Furthermore, the postopera-
tive intracerebral hemorrhage observed in this series is an
adverse event that is not limited to patients who have
undergone therapeutic radiation. The rate of wound-re-
lated complications (2 neck hematomas, 6,6%) was also
comparable, and no perioperative cranial nerve injury or
infection, or delayed wound healing occurred. Neverthe-
less, reports have demonstrated that the diagnosis of cranial
nerve injury is more likely to be established with prospective
studies, especially when they are performed in conjunction
with postoperative testing.20,21 True incidence of cranial
nerve injury may have been underestimated in the present
study.
During follow-up all patients remained asymptomatic
and no carotid occlusions occurred. However, 3 patients
had greater than 60% recurrent stenosis, and 2 of these
patients (80%) underwent repeat operation. In the
present study the risk of greater than 60% recurrent stenosis
at 18 months (3 of 18 patients, 16.6%) was comparable to
that reported by Kashyap el al16 andHassen-Khodja17 et al,
and was higher than that in patients after carotid revascu-
larization without a history of radiation therapy.22,23 That
the three early recurrent stenoses in this series occurred
after revascularization with saphenous vein suggests that
autologous vein may be prone to a significantly higher rate
of recurrent stenosis when carotid revascularization is per-
formed through a radiated field. Rockman et al24 have
made similar observations, finding that prosthetic materials
(bypass graft and patch angioplasty) are associated with
lower rates of recurrent restenosis or occlusion compared
with autologous saphenous vein in repeat carotid surgery.
Although the difference was not statistically significant, it is
interesting to note that there was a shorter interval between
radiation therapy and surgery in patients with recurrent
stenosis and progressive vasculopathy compared with pa-
tients who did not have these complications (5 years vs 11.4
years).
Carotid angioplasty and stenting has been proposed as
the preferred method of treating carotid artery stenosis in
the irradiated neck. Al-Mubarak et al25 reported 15 carotid
angioplasty and stenting procedures in 14 patients, and
Houdart et al26 reported 9 such procedures in 7 patients.
Technical success was achieved in all cases. Al-Mubarak et al
reported one minor stroke, and Houdart et al reported one
TIA, but no other perioperative complications were noted.
During limited follow-up in both series, ie, 18 months and
8 months, respectively, no neurologic events occurred and
no repeat carotid interventions were required. Although
these two reports demonstrate favorable immediate and
short-term outcome, carotid angioplasty and stenting is still
investigational, and its final role as an alternative to surgery
has yet to be determined. The marked amount of periad-
ventitial fibrosis and characteristic long length of these
stenoses may limit the long-term effectiveness of this pro-
cedure.
In conclusion, carotid artery revascularization through
a radiated field can be performed with perioperative risk for
stroke and death that is comparable with that reported in
major clinical trials and other published endarterectomy
series. Notable relief from neurologic symptoms and stroke
was encountered during follow-up, although recurrent ste-
nosis was significant in the cohort of patients with advanced
angiographic and surgical risk factors.
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